![](images/null.gif) |
![](images/null.gif) |
![](images/null.gif) |
|
Incidence and Prevalence of Extrahepatic Manifestations of HCV
|
|
|
Reported by Jules Levin
EASL 2018 April 11-15 Paris France
Hashem El-Serag1,2; Israel C. Christie1,2; Amy Puenpatom3; Diana Castillo1; Fasiha Kanwal1,2; Jennifer R. Kramer1,2
1Center for Innovations in Quality, Effectiveness and Safety (IQuESt), Michael E. DeBakey VA Medical Center, Houston, TX, USA; 2Department of Medicine, Baylor College of Medicine, Houston, TX, USA; 3Merck & Co., Inc., Kenilworth, NJ, USA
![0417181](../images%20/041718/041718-2/0417181.gif)
![0417182](../images%20/041718/041718-2/0417182.gif)
![0417183](../images%20/041718/041718-2/0417183.gif)
![0417184](../images%20/041718/041718-2/0417184.gif)
![0417185](../images%20/041718/041718-2/0417185.gif)
|
|
|
![](images/null.gif) |
![](images/null.gif) |
|
|